» Articles » PMID: 17709599

CHOP Transcription Factor Mediates IL-8 Signaling in Cystic Fibrosis Bronchial Epithelial Cells

Overview
Date 2007 Aug 22
PMID 17709599
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Interleukin (IL)-8 is a potent neutrophil chemoattractant that drives the inflammatory response in cystic fibrosis (CF). Traditional approaches to the pathophysiology of this inflammation have focused on targeting NF-kappaB-dependent signaling and therapy with glucocorticoids. We test the hypothesis that an alternative pathway, independent of NF-kappaB, operates through prostaglandin E2 (PGE-2) receptor EP-2 and stimulates IL-8 chemokine secretion. Using CF bronchial epithelial cells (IB3-1) in vitro, exogenous PGE-2 induces IL-8 release in a dose-dependent manner. These events are associated with elevation in the EP-2 receptors. Inhibition of cyclooxygenase (Cox)-2 with NS-398 was associated with reductions in Cox-2 (2-fold) and IL-6 (1.3-fold) mRNA transcripts, and in IL-8 and PGE-2 chemokine secretion. The inhibition of Cox-2 signaling led to down-regulation of the downstream C/EBP homologous protein (CHOP) transcription factor, resulting in a decrease in IL-8 activation. We confirmed the regulation of IL-8 promoter by CHOP in CF cells using the IL-8 reporter assay. We conclude that PGE-2 stimulates IL-8 production through the CHOP transcription factor in CF cells.

Citing Articles

Protective Effects and Mechanisms of Inhibiting Endoplasmic Reticulum Stress on Cold Seawater Immersion Combined with Hemorrhagic Shock.

Zhou X, Zou L, Deng H, Zhou Y, Wu Y, Ouyang X J Inflamm Res. 2024; 17:4923-4940.

PMID: 39070132 PMC: 11283250. DOI: 10.2147/JIR.S469622.


Oleic acid-induced metastasis of KRAS/p53-mutant colorectal cancer relies on concurrent KRAS activation and IL-8 expression bypassing EGFR activation.

Shen C, Chan R, Lin B, Li N, Huang Y, Chang W Theranostics. 2023; 13(13):4650-4666.

PMID: 37649607 PMC: 10465226. DOI: 10.7150/thno.85855.


ER stress promotes mitochondrial DNA mediated type-1 interferon response in beta-cells and interleukin-8 driven neutrophil chemotaxis.

Vig S, Lambooij J, Dekkers M, Otto F, Carlotti F, Guigas B Front Endocrinol (Lausanne). 2022; 13:991632.

PMID: 36171907 PMC: 9511040. DOI: 10.3389/fendo.2022.991632.


SARS-CoV-2 Envelope (E) Protein Binds and Activates TLR2 Pathway: A Novel Molecular Target for COVID-19 Interventions.

Planes R, Bert J, Tairi S, BenMohamed L, Bahraoui E Viruses. 2022; 14(5).

PMID: 35632741 PMC: 9146335. DOI: 10.3390/v14050999.


Cellular Response to Unfolded Proteins in Depression.

Kowalczyk M, Kowalczyk E, Kwiatkowski P, Lopusiewicz L, Talarowska M, Sienkiewicz M Life (Basel). 2021; 11(12).

PMID: 34947907 PMC: 8707777. DOI: 10.3390/life11121376.


References
1.
Konstan M, Hoppel C, Chai B, DAVIS P . Ibuprofen in children with cystic fibrosis: pharmacokinetics and adverse effects. J Pediatr. 1991; 118(6):956-64. DOI: 10.1016/s0022-3476(05)82218-8. View

2.
Standiford T, Kunkel S, Basha M, Chensue S, Lynch 3rd J, Toews G . Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J Clin Invest. 1990; 86(6):1945-53. PMC: 329830. DOI: 10.1172/JCI114928. View

3.
Marini M, Vittori E, Hollemborg J, Mattoli S . Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. J Allergy Clin Immunol. 1992; 89(5):1001-9. DOI: 10.1016/0091-6749(92)90223-o. View

4.
Donnelly S, Strieter R, Kunkel S, Walz A, ROBERTSON C, Carter D . Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet. 1993; 341(8846):643-7. DOI: 10.1016/0140-6736(93)90416-e. View

5.
Massion P, Inoue H, Grunberger D, Jorens P, Housset B, Pittet J . Novel Pseudomonas product stimulates interleukin-8 production in airway epithelial cells in vitro. J Clin Invest. 1994; 93(1):26-32. PMC: 293717. DOI: 10.1172/JCI116954. View